Developments in breast cancer care
Intended for healthcare professionals
Clinical Previous     Next

Developments in breast cancer care

Abigail Sanders Clinical Nurse Specialist, Dorset Cancer Centre

In many cases, conventional treatments for localised breast cancer do not prevent the development of metastatic disease. Recent developments in the treatment of metastatic breast cancer include monoclonal antibody therapies that work by targeting specific growth factors found in abnormally high numbers in some patients. Within the UK, the treatment is set to become more widely used in the near future for the management of metastatic breast cancer.

Cancer Nursing Practice. 1, 1, 22-25. doi: 10.7748/cnp2002.02.1.1.22.c5

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or